Cronos Group Inc.

CRON

Explore Our Financial Data > Companies > Cronos Group Inc.
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
CRON
CIK0001656472
SIC2833
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupMedicinal Chemicals

Contact

Address4491 CONCESSION RD 12, STAYNER, A6, L0M 1S0
Website thecronosgroup.com
Phone(416) 504-0004
CEOMichael R. Gorenstein
Employees450

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$124.59 million
Pre-Tax Income$46.90 million
Net Income$50.23 million
Net Income to Common$49.44 million
EPS$0.14
View All
Balance Sheet
Cash$797.82 million
Assets$1.15 billion
Liabilities$39.06 million
Common Equity$1.07 billion
Liabilities & Equity$1.15 billion
View All
Cash Flow Statement
Net Income$50.23 million
Cash From Operating Activities$18.95 million
Cash From Investing Activities$-69.76 million
Cash From Financing Activities$-3.52 million
Change in Cash$-57.30 million
View All
Calculations
NOPAT$-69.25 million
EBITDA$-23.48 million
Price to Earnings$14.89
Price to Book$0.69
ROE4.59%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Cronos Group And 2 Other Noteworthy Penny Stocks On The TSX

The Canadian market is currently navigating a complex landscape of trade developments, central bank meetings, and fiscal debates, all contributing to potential volatility. Despite these challenges, the fundamentals remain supportive of growth, providing a backdrop where investors might explore opportunities in various sectors. Though the term 'penny stocks' might feel like a relic from past market eras, they still offer potential for growth when backed by strong financials. In this article,...

Article Link

Pot Stock Euphoria Vanishes as US Legalization Remains Elusive

(Bloomberg) -- The stock market’s marijuana boom is over. And for the once high-flying cannabis industry, a euphoric dream of never-ending growth has turned into a survival nightmare as it navigates through the bust. Most Read from BloombergNext Stop: Rancho Cucamonga!Where Public Transit Systems Are Bouncing Back Around the WorldTrump Said He Fired the National Portrait Gallery Director. She’s Still There.US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents WarnSenator Calls for Clo

Article Link

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group

Article Link

Shareholders Can Be Confident That Cronos Group's (TSE:CRON) Earnings Are High Quality

Cronos Group Inc.'s ( TSE:CRON ) strong earnings report was rewarded with a positive stock price move. Our analysis...

Article Link

Cronos Group First Quarter 2025 Earnings: Beats Expectations

Cronos Group ( TSE:CRON ) First Quarter 2025 Results Key Financial Results Revenue: US$32.3m (up 28% from 1Q 2024). Net...

Article Link